EVALUATION OF IMMUNOHISTOCHEMICAL BIOMARKERS (KI-67, P53, AND HER2) IN BREAST CARCINOMA: CORRELATION WITH TUMOR GRADE AND PROGNOSTIC OUTCOMES
Background: Breast carcinoma had remained one of the most common malignancies affecting women, and accurate assessment of tumor biology had been essential for predicting disease behavior and guiding treatment. Immunohistochemical biomarkers such as Ki-67, p53, and HER2 had provided valuable information regarding cellul...